Published by Coherent Market Insights
Posted on September 30, 2021
Stents are medical devices intended to use for the treatment of blocked vascular paths and the procedure used to reduce the blockages is known as percutaneous transluminal coronary angioplasty (PTCA). The stents used for arterial blockage are known as coronary stents or heart stents. There are three types of stents such as drug eluting stents, bare metal stents, and Bioresorbable Vascular Scaffold. Drug eluting stents are small expandable mesh tube made up of medical-grade stainless steel or cobalt alloy metal, that are inserted into the coronary arteries of patients suffering with atherosclerosis. Stent helps to hold the artery open, to release a drug that prevents blockage in artery and improves blood flow in artery.
Get a Sample Copy of the India Coronary Stents market Report 2021 @
https://www.coherentmarketinsights.com/insight/request-sample/3484
Major Market Players Profiled in the India Coronary Stents Market Report include: Abbott Laboratories, Medtronic, Inc., Biosensors Inc., Terumo Corporation, and Boston Scientific Inc.
Increasing prevalence of coronary heart disease is a major factor boosting growth of India coronary stents market over the forecast period. For instance, according to the study ‘Divergent trends in ischaemic heart disease and stroke mortality in India from 2000 to 2015: a nationally representative mortality study’, published in the journal Lancet in August 2018, heart ailments caused more than 2.1 million deaths in India in 2015 at all ages. Moreover, 0.9 million deaths were caused by coronary heart disease and 0.4 million by stroke in the year.
Moreover, high adoption of stents in treatment of cardiovascular blockage is also expected to aid in growth of the market. Stents implantation is highly preferred as compared to more invasive bypass surgeries, owing to non-invasive nature, which offers less discomfort and shorter recovery time for patients.
The market is witnessing increasing adoption of PCI. For instance, according to a report by National Intervention Council , India, and Apollo Health City, India, published in April 2019, a total of 3,87,416 PCI procedures were performed in 705 centers in India in 2017, which accounted for a 3.7% growth compared to that in 2016.
The prices of coronary stents have decreased significantly in India, owing to capping of the sale price of coronary stents by the Government of India in February 2017. The market witnessed 80% decrease in prices of coronary stents. However, in April 2019, National Pharmaceutical Pricing Authority (NPPA) approved hike in prices of cardiac stents by 4.2% in-line with the wholesale price index (WPI) of 2018.
The use of a balloon coated with paclitaxel and iopromide is preferred over bare-metal stents in patients with high bleeding risk undergoing PCI. According to the results of the single-blind, randomized, noninferiority DEBUT trial conducted by researchers from Harvard Medical School and published in The Lancet in May 2019, PCI with drug-eluting balloons is noninferior to PCI with bare-metal stents for treatment of de novo coronary artery lesions in patients with high bleeding risk.
Ask for PDF sample copy of the India Coronary Stents market report @
https://www.coherentmarketinsights.com/insight/request-pdf/3484
Table of Content
Global India Coronary Stents Market Research Report
Section 1: Global India Coronary Stents Industry Overview
Section 2: Global Economic Impact on India Coronary Stents Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: India Coronary Stents Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global India Coronary Stents Market Forecast
Reasons to purchase this research report:
• Data regarding the industry share by every item fragment, alongside their reasonable worth, have been served in the report.
• We provide statistic information, strategic and analysis tool results to provide a sophisticated landscape and target key market players.
• Our report helps readers decipher the current and future constraints of the market and optimal business strategies to enhance market development.
• Our reports have been examined by professional experts of the industry, which makes them beneficial for the company to maximize their return on investment.
• The analysis acknowledges that the sector players & key drivers of both conflicts and growth assess the impact of limitations as well as the opportunities on the sector.
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/3484
Some Questions Answered in this Report:
• What are the winning strategies of stakeholders in the India Coronary Stents market to upscale their position in this landscape?
• Which companies are leading the India Coronary Stents market?
• Which regions will continue to remain the most profitable regional markets for India Coronary Stents market players?
• Which factors will induce a change in the demand for India Coronary Stents during the assessment period?
• How will changing trends impact the India Coronary Stents market?
• How can market players capture the low-hanging opportunities in the India Coronary Stents market in developed regions?
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post India coronary stents market to reach US$ 2,049.9 Mn by the end of 2027, at a CAGR of 14.0% | Increasing investments in research and development activities appeared first on Gatorledger.
Stents are medical devices intended to use for the treatment of blocked vascular paths and the procedure used to reduce the blockages is known as percutaneous transluminal coronary angioplasty (PTCA). The stents used for arterial blockage are known as coronary stents or heart stents. There are three types of stents such as drug eluting stents, bare metal stents, and Bioresorbable Vascular Scaffold. Drug eluting stents are small expandable mesh tube made up of medical-grade stainless steel or cobalt alloy metal, that are inserted into the coronary arteries of patients suffering with atherosclerosis. Stent helps to hold the artery open, to release a drug that prevents blockage in artery and improves blood flow in artery.
Get a Sample Copy of the India Coronary Stents market Report 2021 @
https://www.coherentmarketinsights.com/insight/request-sample/3484
Major Market Players Profiled in the India Coronary Stents Market Report include: Abbott Laboratories, Medtronic, Inc., Biosensors Inc., Terumo Corporation, and Boston Scientific Inc.
Increasing prevalence of coronary heart disease is a major factor boosting growth of India coronary stents market over the forecast period. For instance, according to the study ‘Divergent trends in ischaemic heart disease and stroke mortality in India from 2000 to 2015: a nationally representative mortality study’, published in the journal Lancet in August 2018, heart ailments caused more than 2.1 million deaths in India in 2015 at all ages. Moreover, 0.9 million deaths were caused by coronary heart disease and 0.4 million by stroke in the year.
Moreover, high adoption of stents in treatment of cardiovascular blockage is also expected to aid in growth of the market. Stents implantation is highly preferred as compared to more invasive bypass surgeries, owing to non-invasive nature, which offers less discomfort and shorter recovery time for patients.
The market is witnessing increasing adoption of PCI. For instance, according to a report by National Intervention Council , India, and Apollo Health City, India, published in April 2019, a total of 3,87,416 PCI procedures were performed in 705 centers in India in 2017, which accounted for a 3.7% growth compared to that in 2016.
The prices of coronary stents have decreased significantly in India, owing to capping of the sale price of coronary stents by the Government of India in February 2017. The market witnessed 80% decrease in prices of coronary stents. However, in April 2019, National Pharmaceutical Pricing Authority (NPPA) approved hike in prices of cardiac stents by 4.2% in-line with the wholesale price index (WPI) of 2018.
The use of a balloon coated with paclitaxel and iopromide is preferred over bare-metal stents in patients with high bleeding risk undergoing PCI. According to the results of the single-blind, randomized, noninferiority DEBUT trial conducted by researchers from Harvard Medical School and published in The Lancet in May 2019, PCI with drug-eluting balloons is noninferior to PCI with bare-metal stents for treatment of de novo coronary artery lesions in patients with high bleeding risk.
Ask for PDF sample copy of the India Coronary Stents market report @
https://www.coherentmarketinsights.com/insight/request-pdf/3484
Table of Content
Global India Coronary Stents Market Research Report
Section 1: Global India Coronary Stents Industry Overview
Section 2: Global Economic Impact on India Coronary Stents Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: India Coronary Stents Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global India Coronary Stents Market Forecast
Reasons to purchase this research report:
• Data regarding the industry share by every item fragment, alongside their reasonable worth, have been served in the report.
• We provide statistic information, strategic and analysis tool results to provide a sophisticated landscape and target key market players.
• Our report helps readers decipher the current and future constraints of the market and optimal business strategies to enhance market development.
• Our reports have been examined by professional experts of the industry, which makes them beneficial for the company to maximize their return on investment.
• The analysis acknowledges that the sector players & key drivers of both conflicts and growth assess the impact of limitations as well as the opportunities on the sector.
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/3484
Some Questions Answered in this Report:
• What are the winning strategies of stakeholders in the India Coronary Stents market to upscale their position in this landscape?
• Which companies are leading the India Coronary Stents market?
• Which regions will continue to remain the most profitable regional markets for India Coronary Stents market players?
• Which factors will induce a change in the demand for India Coronary Stents during the assessment period?
• How will changing trends impact the India Coronary Stents market?
• How can market players capture the low-hanging opportunities in the India Coronary Stents market in developed regions?
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post India coronary stents market to reach US$ 2,049.9 Mn by the end of 2027, at a CAGR of 14.0% | Increasing investments in research and development activities appeared first on Gatorledger.
Explore more articles in the Research Reports category
